Refractory Cytopenias
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) (NCT00303472) | Amgen | 2006-02-01 |
Track Refractory Cytopenias automatically
Every clearance here is in the API, with alerts when new ones post.